TriSalus Life Sciences (TLSIW) Change in Taxes (2022 - 2023)

TriSalus Life Sciences (TLSIW) reported Change in Taxes of -$24278.0 for Q2 2023, down 189.53% quarter-over-quarter from $27118.0 in Q1 2023.

TriSalus Life Sciences (TLSIW) Change in Taxes (2022 - 2023) Analysis & Trends

TriSalus Life Sciences has reported Change in Taxes for 2 years, with the latest figure at -$24278.0 in Q2 2023.

For the quarter ending Q2 2023, Change in Taxes changed N/A year-over-year to -$24278.0; the trailing twelve-month figure through Jun 2023 stood at $2492.0 (changed N/A YoY), and the FY2022 full-year result was $27854.0, changed N/A from the prior year.
Change in Taxes for Q2 2023 stood at -$24278.0, down from $27118.0 in the prior quarter.
The five-year high for Change in Taxes was $135284.0 in Q3 2022, with the low at -$135632.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	42.00 Mn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	41.90 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	TriSalus Life Sciences	-	-	7.67 Mn	-

Download Data